Physician profile
Scott Calig
NPI 1306864921
$434.97
in general payments reported to CMS, 2019-2025
10 companies · $345 in 2025
The $345 reported for 2025 was more than what 87% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.81 · 2024: $70.18 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.16 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $118.74 | 2023-2025 | Gardasil 9, Vaxneuvance, Varivax |
| Abbott Laboratories | $51.54 | 2025 | Id Now Instrument |
| Cranial Technologies, INC | $50.77 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $50.39 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $47.59 | 2025 | Neffy |
| Mayne Pharma Commercial LLC | $39.94 | 2025 | |
| Sanofi-Aventis U.S. LLC | $20.53 | 2025 | |
| Neos Therapeutics, LP | $19.33 | 2025 | Adzenys Xr-Odt |
| Phadia US INC. | $18.75 | 2025 | Immunocap |
| Seqirus USA INC | $17.39 | 2025 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Calig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.